improved disease-free survival with osimertinib in egfr lung cancer
Published 3 years ago • 95 plays • Length 7:11Download video MP4
Download video MP3
Similar videos
-
1:15
osimertinib improves survival in egfr nsclc, poses new challenges for resistance
-
2:20
osimertinib with chemotherapy in egfr-mutated nsclc | nejm
-
6:00
osimertinib improves pfs in egfr-mutant, unresectable, stage iii nsclc
-
7:53
improved progression-free survival with iressa as adjuvant therapy
-
2:18
prolonging survival in nsclc
-
3:09
case 2: osimertinib in egfr-mutated lung cancer
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
2:33
adaura: osimertinib adjuvant therapy in egfr mutated nsclc
-
55:38
novel therapy for lung cancer: from targeted therapy to immuno-therapy and back again!
-
3:02
osimertinib in advanced egfr t790m-mutant nsclc
-
1:23
flaura trial demonstrates efficacy in egfr-positive lung cancer
-
1:35
dr. herbst on the benefit of adjuvant osimertinib in egfr-mutant nsclc
-
4:44
is disease-free survival a meaningful endpoint in nsclc? - medpage today
-
5:06
front-line osimertinib significantly lengthens overall survival in egfr-mutation positive nsclc
-
5:54
key points from the adaura trial: osimertinib - targeted therapies in lung cancer 2023
-
2:20
adjuvant osimertinib in resected egfrm nsclc: the os data from the adaura trial
-
0:54
lung cancer can now be treated by a tablet called osimertinib, tagrisso. part 3 #cancer